Media/Policy Watch

Media/Policy Watch
This watch section is intended to alert readers to substantive news, analysis and opinion from the general media and selected think tanks and similar organizations on vaccines, immunization, global public health and related themes. Media Watch is not intended to be exhaustive, but indicative of themes and issues CVEP is actively tracking. This section will grow from an initial base of newspapers, magazines and blog sources, and is segregated from Journal Watch above which scans the peer-reviewed journal ecology.
We acknowledge the Western/Northern bias in this initial selection of titles and invite suggestions for expanded coverage. We are conservative in our outlook in adding news sources which largely report on primary content we are already covering above. Many electronic media sources have tiered, fee-based subscription models for access. We will provide full-text where content is published without restriction, but most publications require registration and some subscription level.
The sheer volume of vaccine and pandemic-related coverage is extraordinary. We will strive to present the most substantive analysis and commentary we encounter.


The Atlantic
Accessed 8 May 2021
[No new, unique, relevant content]


Accessed 8 May 2021
Covid: Macron calls on US to drop vaccine export bans
8 May 2021


The Economist
Accessed 8 May 2021
Home brewing
Covid-19 has exposed Africa’s dependence on vaccines from abroad
There is a big push to change this
Middle East & Africa May 8th 2021 edition

Paper tiger
India’s national government looks increasingly hapless
Confronted with catastrophe, the state has melted away
May 8th 2021 edition

Daily chart
Global herd immunity is still out of reach
Vaccine hesitancy threatens the pandemic response
May 8th 2021 edition

Daily chart
Covid-19 vaccine donations have yet to take off
Less than one dose for every 100 of the world’s people has been given away


Financial Times
Accessed 8 May 2021
News in-depth
Serum Institute of India
How the world’s top vaccine maker struggled to meet the moment
Adar Poonawalla and Serum Institute have come under withering criticism as Covid ravages India

Stephanie Findlay in New Delhi and Benjamin Parkin in Bangalore
…But four months on, Poonawalla is facing a reckoning as India staggers under a brutal second wave of infections. Despite warning that it would take until 2024 to inoculate the world, his company has been vilified over allegations of price gouging and its failure to meet its overseas vaccine demands. His decision to decamp to his London mansion before the UK barred flights from India was condemned across his home country.
The Serum Institute has also been hit by lawsuits from global governments for failing to meet contractual agreements for supplies, while Poonawalla said threats had been made against him. The Indian government has provided him with security guards.
Poonawalla was also blamed for just 2 per cent of India being fully vaccinated. But he has pointed out that the government had not placed enough orders ahead of the second wave. “I’m just the manufacturer,” he told the Financial Times after claiming he had been “victimised” over the stuttering vaccine campaign. “I don’t decide these policies.”
He admitted though that he has had “to grow a thicker skin”.
“History will have to judge the work that the company has done, and whether we have profited here, or whether we have served the nation,” he said…

Melinda Gates: vaccines, inequality and caregiving
…But if you look at the current system, the AstraZeneca vaccine, we’ve been deeply involved in the tech transfer that happened to Serum Institute in India, they are pumping out millions of doses every month…
May 4, 2021
Top of Form
Bottom of Form

The FT View The editorial board
How to step up vaccine supplies to poorer countries
May 4, 2021


Accessed 8 May 2021
May 7, 2021
Patent Waivers Won’t Impact Big Pharma’s Bottom Line—But Could Slow Covid Vaccine Rollouts
Analysts say intellectual property waivers won’t affect vaccine makers Moderna, Pfizer or Novavax—but could paradoxically risk slowing down vaccine production.
By Alex Knapp Forbes Staff

May 6, 2021
May U.S. Travel Restrictions By State: Vaccinations, Quarantine, Covid-19 Test Requirements
The state-by-state picture of U.S. travel restrictions, quarantine and Covid-19 testing requirements for May 2021 shows a country increasingly vaccinated, optimistic and on the move.
By Alex Ledsom Senior Contributor


Foreign Affairs
Accessed 8 May 2021
[No new, unique, relevant content]


Foreign Policy
Accessed 8 May 2021
Stopping Drug Patents Has Stopped Pandemics Before
Loosening property rules over coronavirus vaccines is likely to accelerate—not stifle—the pharmaceutical industry’s creativity.
| Laurie Garrett May 7, 2021, 12:00 PM


New Yorker
Accessed 8 May 2021
Medical Dispatch
Inside India’s COVID-19 Surge
At a hospital in New Delhi, supplies and space are running out, but the patients keep coming.
By Dhruv Khullar
May 4, 2021


New York Times
Accessed 8 May 2021
India and Its Vaccine Maker Stumble Over Their Pandemic Promises
The Serum Institute vowed to protect the country from Covid-19 and inoculate the world’s poor, but India’s crisis has pushed it past its limits.
By Emily Schmall and Karan Deep Singh May 7

Baltimore Vaccine Plant’s Troubles Ripple Across 3 Continents
Millions of doses of Johnson & Johnson’s Covid-19 vaccine produced by Emergent BioSolutions have been held back in Europe, South Africa and Canada as a precaution.
By Chris Hamby, Sharon LaFraniere and Sheryl Gay Stolberg May 6


Washington Post
Accessed 8 May 2021
[No new, unique, relevant content]